DRUG insider buying and SEC filings, explained
Bright Minds Biosciences Inc. · CIK 1827401
Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- A1
- Fiscal year end
- Sep 30
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$9.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 28, 2026 | Sale | Bihua Chen (Former 10% Owner) sold 109,331 shares indirectly at $89.50 ($9.8M). Indirect holdings down 10% to 950,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Apr 30, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DRUG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.